Last --
Change Today 0.00 / 0.00%
Volume 0.0
4519 On Other Exchanges
Symbol
Exchange
4519 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yasunori Fujii

Former Corporate Auditor, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

73--

Background*

Mr. Yasunori Fujii has been Professor at Shizuoka Industrial University since April, 2002. Mr. Fujii served as Director, London Branch, The Long-Term Credit Bank of Japan, Ltd. since June 1991; Managing Director, Kumagai Gumi Co., Ltd. since June 1993; Senior Managing Director, International Division since April 1995. He served as a Auditor of Risa Partners, Inc. since March 2002. He has been Auditor of Chugai Pharmaceutical Co., Ltd. since March 2004. Mr. Fujii served ...

Read Full Background

Corporate Headquarters*

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

Former Corporate Auditor
Former Part Time Auditor
2002-N/A
Former Corporate Auditor

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4519:JP ¥3,680.00 JPY -65.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Karl-Ludwig Kley Chairman of Executive Board
Merck KGaA
€5.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.